Logotype for ICU Medical Inc

ICU Medical (ICUI) Q4 2020 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for ICU Medical Inc

Q4 2020 earnings summary

6 Nov, 2026

Executive summary

  • Revenue grew to $1.271B in 2020 from $1.266B in 2019 despite COVID-19 disruption; stronger Infusion Systems sales offset weaker Consumables and IV Solutions demand.

  • Infusion pump growth included the first annual increase in U.S. pump sales since the 2017 Hospira acquisition; free cash flow was described as the strongest in company history.

  • Management cited improved market position, product mix and customer relationships as foundations for 2021, while retaining a conservative capital structure.

Financial highlights

  • FY2020 revenue $1,271.0M vs. $1,266.2M in 2019; operating income $98.2M vs. $107.4M; net income $86.9M vs. $101.0M.

  • Diluted EPS was $4.02 vs. $4.69 in 2019; cash from operations increased to $222.8M from $101.9M.

  • Gross profit was $461.5M and gross margin 36.3% vs. 37.3% in 2019; lower IV Solutions manufacturing volumes and unfavorable consumables mix weighed on margin.

  • Operating expenses included $28.4M in restructuring, strategic transaction and integration costs, plus a $9.0M increase in the Pursuit earn-out fair value.

Outlook and guidance

  • 2021 capital expenditures estimated at $75M-$85M, mainly for manufacturing machinery and equipment and infusion pumps placed with customers outside the U.S.

  • Existing cash, cash equivalents and expected operating cash generation were expected to fund operations for the next 12 months; management retained the $150M revolving facility for flexibility.

  • Management anticipated a gradual return toward normal hospital utilization in 2021 and expected growth products, including ChemoLock, ChemoClave and ClearGuard, to support Consumables.

  • Several critical new regulatory filings were planned for 2021; management expressed hope for a more normal operating environment as vaccines and therapies improved the pandemic outlook.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from ICU Medical